AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Clinical trials for AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE explained in plain language.
Never miss a new study
Get alerted when new AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE trials appear
Sign up with your email to follow new studies for AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hope for Alzheimer's caregivers: new drug targets agitation
Symptom relief CompletedThis study tested an experimental drug called AXS-05 to see if it can safely reduce agitation in people with Alzheimer's disease. About 408 participants took either the drug or a placebo for several weeks. The goal was to measure changes in agitation using a standard rating scale…
Matched conditions: AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 22, 2026 14:05 UTC
-
New drug calms Alzheimer's agitation in Long-Term trial
Symptom relief CompletedThis study looked at the long-term safety and effectiveness of a drug called AXS-05 for treating agitation in people with Alzheimer's disease. 456 participants who had already been in earlier studies took the drug, and some later switched to a placebo to see if agitation symptoms…
Matched conditions: AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC